ASIASTUDIO: Dr. Kelly H. Zou, a leading expert in statistics and former vice president at Pfizer, discusses the future of health data, drug research, and artificial intelligence with Mikko Alkio. Topics include the advances of the European Health Data Space, the unique quality of Nordic registries, the role of genomic data in preventive care, and the balance between privacy and public health. Zou also opens up about her work as an Anthropic community ambassador and compares startup ecosystems in the United States, Europe, and China. A candid and at times provocative conversation about how data could be better used for the benefit of patients. Aloita ilmainen 14 päivän kokeilu: www.asiastudio.fi. Asiastudio app on nyt ladattavissa App Storesta tai Google Playsta. 00:00 Intro 00:57 Zou's background 04:24 Zou's books and the evolution of her research from imaging to AI 09:00 Pharmaceutical industry regulation, clinical trial challenges, and data siloing 10:19 The European Health Data Space and its regulatory framework 13:47 Comparison of US and Nordic data sources and registry quality 18:00 Differences in resources between large pharma and biotech firms, and precision data strategy 19:36 Genomic data in layman's terms: biobanks, 23andMe, and the Swedish twin study 23:15 Imaging, AI, and the role of genomic data in understanding the individual 24:51 Genomic data privacy, GDPR, and Alkio's personal view 26:53 Question about data-driven prevention at Mayo Clinic and other clinics 28:00 Zou's personal experience of an early cancer diagnosis and biobank study 30:47 The impact of genomic data on preventive care and research needs 32:25 Alkio's example of a Spanish health center and pragmatic prevention 35:40 Turning research findings into action and the role of decision-makers 37:38 The role of regulators, payers, and real-world data in approval, and ARPA-H 39:16 Privacy, the principle of proportionality, and Alkio's provocative question about data use 42:01 Privacy in the age of generative AI and the technical challenges of data protection 44:38 The contradiction between social media data and health data in privacy 46:05 Data ownership and patients' rights to their own data 48:54 Healthcare system incentives and Alkio's critique of the Finnish model 51:23 Anthropic community ambassador work and Zou's roles 52:18 AI workshop in New York, hackathon, and open data 55:26 Poulevard Tech's market entry and the role of the startup community 56:52 Differences in startup ecosystems on the East and West Coasts 58:14 Comparison of different research and startup regions in the United States 59:03 Tech Week events and customer-centricity in entrepreneurship 1:01:37 Differences in entrepreneurial spirit between Europe and the United States 1:02:00 Shanghai, New York, and the dynamism of cities 1:03:43 Highlighting Helsinki and cultural similarities 1:04:56 China's technological development in healthcare and examples 1:06:38 Technology, trust, and Europe's caution, plus biometrics 1:08:07 China's execution capability, democracy, and effective use of technology 1:10:03 China's innovation culture and historical pride in inventions 1:11:30 The responsibility of health policy, the principle of proportionality, and closing remarks 1:13:44 Light closing, basketball game, and goodbyes
